financetom
Business
financetom
/
Business
/
Should you buy IT stocks even after their superb run? Yes, says HDFC sec
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Should you buy IT stocks even after their superb run? Yes, says HDFC sec
Oct 8, 2020 8:35 AM

The Nifty IT has outperformed the markets by more than 40 percent so far this year and nearly every stock in the index has done well. The large caps have clocked gains of about 50 percent barring TCS, which is up about 30 percent since the start of the year.

Share Market Live

NSE

Investors can look at IT stocks even at these levels, Apurva Prasad, Research Analyst IT at HDFC Securities said in an interview to CNBC-TV18.

Prasad said that tech budgets were getting priority and that incremental revenue addition for IT companies over the next couple of years will be higher than that in the last four years.

He sees good upside in IT stocks over the next one-two years despite the 20-25 percent outperformance versus Nifty.

He said many midcap IT companies will be able to scale up.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says
Apr 17, 2024
April 17 (Reuters) - The U.S. Food and Drug Administration website showed that most doses of Eli Lilly's ( LLY ) diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand. The health regulator's website noted limited availability of the 5 milligram (mg), 7.5 mg, 10 mg,...
Vanda Pharmaceuticals' Board Rejects all Unsolicited Takeover Proposals From Future Pak
Vanda Pharmaceuticals' Board Rejects all Unsolicited Takeover Proposals From Future Pak
Apr 17, 2024
09:58 AM EDT, 04/17/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said Wednesday that its board has unanimously rejected all unsolicited proposals from Future Pak to acquire all outstanding shares of the company, including the most recent proposal, which was made on April 1, for $7.25 to $7.75 per share. The biopharmaceutical firm said the board has concluded the...
MSCI Closes Acquisition of Foxberry
MSCI Closes Acquisition of Foxberry
Apr 17, 2024
09:17 AM EDT, 04/17/2024 (MT Newswires) -- MSCI ( MSCI ) said Wednesday that it has closed its acquisition of index technology provider Foxberry. Financial terms of the deal were not disclosed. ...
Loar Planning Planning US IPO of 11 Million Shares
Loar Planning Planning US IPO of 11 Million Shares
Apr 17, 2024
09:42 AM EDT, 04/17/2024 (MT Newswires) -- Loar Holdings said Wednesday that it plans to launch a US initial public offering price of 11 million shares at a price between $24 and $26 a share. The maker of aerospace parts said it has applied to list the shares on the NYSE under the ticker LOAR, according to a filing with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved